Abstract
Fragment-based drug design (FBDD) comprises both fragment-based screening (FBS) to find hits and elaboration of these hits to lead compounds. Typical fragment hits have lower molecular weight (<300–350 Da) and lower initial potency but higher ligand efficiency when compared to those from high-throughput screening. NMR spectroscopy has been widely used for FBDD since it identifies and localizes the binding site of weakly interacting hits on the target protein. Here we describe ligand-based NMR methods for hit identification from fragment libraries and for functional cross-validation of primary hits.
Key words
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hajduk PJ, Greer J (2007) A decade of fragment-based drug design: strategic advances and lessons learned. Nat Rev Drug Discov 6:211–219
Harner MJ et al (2013) Fragment-based drug discovery using NMR spectroscopy. J Biomol NMR 56:65–75
Wyss DF et al (2012) Combining NMR and X-ray crystallography in fragment-based drug discovery: discovery of highly potent and selective BACE-1 inhibitors. Top Curr Chem 317:83–114
Congreve M et al (2003) A ‘rule of three’ for fragment-based lead discovery? Drug Discov Today 8:876–877
Lau WF et al (2011) Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics. J Comput Aided Mol Des 25:621–636
Eaton HL, Wyss DF (2011) Effective progression of nuclear magnetic resonance-detected fragment hits. Methods Enzymol 493:447–468
Dalvit C et al (2006) NMR-based quality control approach for the identification of false positives and false negatives in high throughput screening. Curr Drug Discov Technol 3:115–124
Campos-Olivas R (2011) NMR screening and hit validation in fragment based drug discovery. Curr Top Med Chem 11:43–67
Hajduk PJ et al (1999) NMR-based screening in drug discovery. Q Rev Biophys 32:211–240
Jahnke W et al (2001) Spin label enhanced NMR screening. J Am Chem Soc 123:3149–3150
Pellecchia M et al (2008) Perspectives on NMR in drug discovery: a technique comes of age. Nat Rev Drug Discov 7:738–745
Fernandez C, Jahnke W (2004) New approaches for NMR screening in drug discovery. Drug Discov Today Technol 1:277–283
Ludwig C, Guenther UL (2009) Ligand based NMR methods for drug discovery. Front Biosci (Landmark Ed) 14:4565–4574
Mayer M, Meyer B (1999) Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew Chem Int Ed Engl 38:1784–1788
Claasen B et al (2005) Direct observation of ligand binding to membrane proteins in living cells by a saturation transfer double difference (STDD) NMR spectroscopy method shows a significantly higher affinity of integrin alpha(IIb)beta3 in native platelets than in liposomes. J Am Chem Soc 127:916–919
Dalvit C et al (2000) Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water. J Biomol NMR 18:65–68
Dalvit C et al (2003) A general NMR method for rapid, efficient, and reliable biochemical screening. J Am Chem Soc 125:14620–14625
Manzenrieder F et al (2008) Phosphorus NMR spectroscopy as a versatile tool for compound library screening. Angew Chem Int Ed Engl 47:2608–2611
Vanwetswinkel S et al (2005) TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery. Chem Biol 12:207–216
McCoy MA et al (2005) Screening of protein kinases by ATP-STD NMR spectroscopy. J Am Chem Soc 127:7978–7979
Dalvit C et al (2004) Reliable high-throughput functional screening with 3-FABS. Drug Discov Today 9:595–602
Tung JC et al (2000) On the 1H NMR chemical shift assignments for ampicillin. Magn Reson Chem 38:126–128
Acknowledgements
We would like to thank Yan Hou and Mark McCoy for developing the 1D proton NMR-based functional assay and Hugh Eaton and Corey Strickland for valuable discussions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Kim, HY., Wyss, D.F. (2015). NMR Screening in Fragment-Based Drug Design: A Practical Guide. In: Hempel, J., Williams, C., Hong, C. (eds) Chemical Biology. Methods in Molecular Biology, vol 1263. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2269-7_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2269-7_16
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2268-0
Online ISBN: 978-1-4939-2269-7
eBook Packages: Springer Protocols